Agenus (AGEN) Gains from Investment Securities (2014 - 2023)
Agenus' (AGEN) quarterly Gains from Investment Securities came in at -$158000.0 in Q4 2023, down 217.04% year-on-year from $135000.0 in Q4 2022, and down 2075.0% quarter-over-quarter from $8000.0 in Q2 2023.
Agenus (AGEN) Gains from Investment Securities (2014 - 2023) Analysis & Trends
Agenus' Gains from Investment Securities history runs 10 years deep, the most recent figure standing at -$158000.0 for Q4 2023.
- On a quarterly basis, Gains from Investment Securities fell 217.04% year-over-year to -$158000.0 in Q4 2023; TTM through Dec 2023 was -$556000.0, a 31.78% increase from a year earlier, with the FY2024 full-year figure at -$4.0 million, down 611.15% from the prior year.
- Gains from Investment Securities eased to -$158000.0 in Q4 2023 per AGEN's latest filing, from $8000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $14.3 million in Q2 2021 and bottomed at -$4.4 million in Q1 2020.
- The 5-year median for Gains from Investment Securities is -$7000.0 (2022), against an average of $901894.7.
- Biggest YoY gain for Gains from Investment Securities was 3722.31% in 2019; the steepest drop was 889.44% in 2019.
- Year by year, Gains from Investment Securities stood at $4.6 million in 2019, then sank by 174.18% to -$3.4 million in 2020, then surged by 40.25% to -$2.0 million in 2021, then soared by 106.59% to $135000.0 in 2022, then plunged by 217.04% to -$158000.0 in 2023.
- Per Business Quant, the three latest AGEN Gains from Investment Securities figures stand at -$158000.0 (Q4 2023), $8000.0 (Q2 2023), and -$406000.0 (Q1 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Agenus | 234.10 Mn | 199.10 Mn | 33.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -158,000.00 |
| Dec 31, 2023 | -158,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 8,000.00 |
| Mar 31, 2023 | -406,000.00 |
| Mar 31, 2023 | -406,000.00 |
| Dec 31, 2022 | 135,000.00 |
| Dec 31, 2022 | 135,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Sep 30, 2022 | -7,000.00 |
| Jun 30, 2022 | -407,000.00 |
| Jun 30, 2022 | -407,000.00 |
| Mar 31, 2022 | -536,000.00 |
| Mar 31, 2022 | -536,000.00 |
| Dec 31, 2021 | -2.05 Mn |
| Dec 31, 2021 | -2.05 Mn |
| Sep 30, 2021 | 275,000.00 |
| Sep 30, 2021 | 275,000.00 |
| Jun 30, 2021 | 14.30 Mn |
| Jun 30, 2021 | 14.30 Mn |